Azithromycin Blocks Quorum Sensing and Alginate Polymer Formation and Increases the Sensitivity to Serum and Stationary-Growth-Phase Killing of Pseudomonas aeruginosa and Attenuates Chronic P. aeruginosa Lung Infection in Cftr−/− Mice

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2007-07-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.01011-06PMID 17620382PMCID PMC2043275
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quorum-sensing-deficient (lasR) mutants emerge at high frequency from a Pseudomonas aeruginosa mutS strain.

  2007cited by this paper
• Quorum-Sensing Antagonistic Activities of Azithromycin in Pseudomonas aeruginosa PAO1: a Global Approach

  2006influential reference
• Pharmacokinetics of Azithromycin in Plasma, Blood, Polymorphonuclear Neutrophils and Sputum During Long-Term Therapy in Patients With Cystic Fibrosis

  2006cited by this paper
• Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients.

  2006cited by this paper
• Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study.

  2005cited by this paper
• Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent.

  2005cited by this paper
• Novel Mouse Model of Chronic Pseudomonas aeruginosa Lung Infection Mimicking Cystic Fibrosis

  2005cited by this paper
• Quorum-Sensing-Negative (lasR) Mutants of Pseudomonas aeruginosa Avoid Cell Lysis and Death

  2005cited by this paper
• Activities of Pseudomonas aeruginosa Effectors Secreted by the Type III Secretion System In Vitro and during Infection

  2005cited by this paper
• Azithromycin Exhibits Bactericidal Effects on Pseudomonas aeruginosa through Interaction with the Outer Membrane

  2005influential reference
• MucA-Mediated Coordination of Type III Secretion and Alginate Synthesis in Pseudomonas aeruginosa

  2004cited by this paper
• Azithromycin Retards Pseudomonas aeruginosa Biofilm Formation

  2004cited by this paper
• Developmental stability in a cystic fibrosis mouse model

  2004cited by this paper
• Effect of Erythromycin on Chronic Respiratory Infection Caused by Pseudomonas aeruginosa with Biofilm Formation in an Experimental Murine Model

  2004cited by this paper
• Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial.

  2003cited by this paper
• Biofilm formation by Pseudomonas aeruginosa: role of the C4-HSL cell-to-cell signal and inhibition by azithromycin.

  2003cited by this paper
• Microarray Analysis of Global Gene Expression in Mucoid Pseudomonas aeruginosa

  2003cited by this paper
• Pseudomonas aeruginosa quorum sensing as a potential antimicrobial target.

  2003cited by this paper
• The dual roles of AlgG in C‐5‐epimerization and secretion of alginate polymers in Pseudomonas aeruginosa

  2003cited by this paper
• Quorum Sensing Is Not Required for Twitching Motility in Pseudomonas aeruginosa

  2002cited by this paper
• Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial.

  2002cited by this paper
• Extracellular DNA required for bacterial biofilm formation.

  2002cited by this paper
• Persistent infections and immunity in cystic fibrosis.

  2002cited by this paper
• Dynamics of nasopharyngeal colonization by potential respiratory pathogens.

  2002cited by this paper
• Effect of clarithromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model.

  2002cited by this paper
• Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial

  2002cited by this paper
• Macrolide-treated Pseudomonas aeruginosa induces paradoxical host responses in the lungs of mice and a high mortality rate.

  2002cited by this paper
• Detection of Pseudomonas aeruginosa cell-to-cell signals in lung tissue of cystic fibrosis patients.

  2002cited by this paper
• Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound.

  2002cited by this paper
• Azithromycin Inhibits Quorum Sensing in Pseudomonas aeruginosa

  2001influential reference
• Biofilm exopolysaccharides: a strong and sticky framework.

  2001cited by this paper
• PlantsP: a functional genomics database for plant phosphorylation

  2001cited by this paper
• Airway biofilm disease.

  2001cited by this paper
• N-acylhomoserine-lactone-mediated communication between Pseudomonas aeruginosa and Burkholderia cepacia in mixed biofilms.

  2001cited by this paper
• Alginate Overproduction Affects Pseudomonas aeruginosa Biofilm Structure and Function

  2001cited by this paper
• Role of Alginate and Its O Acetylation in Formation of Pseudomonas aeruginosa Microcolonies and Biofilms

  2001cited by this paper
• Role of Alginate O Acetylation in Resistance of Mucoid Pseudomonas aeruginosa to Opsonic Phagocytosis

  2001cited by this paper
• Detection of simple mutations and polymorphisms in large genomic regions.

  2001cited by this paper
• Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth.

  2001cited by this paper
• Bacterial Quorum Sensing in Pathogenic Relationships

  2000cited by this paper
• Detection of N-acylhomoserine lactones in lung tissues of mice infected with Pseudomonas aeruginosa.

  2000cited by this paper
• Potential of macrolide antibiotics to inhibit protein synthesis of Pseudomonas aeruginosa: suppression of virulence factors and stress response

  2000cited by this paper
• Effect of Subinhibitory Concentrations of Macrolides on Expression of Flagellin in Pseudomonas aeruginosa and Proteus mirabilis

  2000cited by this paper
• Excretion of β-Lactam Antibiotics in Sweat—a Neglected Mechanism for Development of Antibiotic Resistance?

  2000cited by this paper
• Identification of genes controlled by quorum sensing in Pseudomonas aeruginosa.

  1999cited by this paper
• Quorum sensing in Pseudomonas aeruginosa controls expression of catalase and superoxide dismutase genes and mediates biofilm susceptibility to hydrogen peroxide

  1999cited by this paper
• Protective Role of Catalase in Pseudomonas aeruginosa Biofilm Resistance to Hydrogen Peroxide

  1999cited by this paper
• Chitinolytic activity of Pseudomonas fluorescens isolates from barley and sugar beet rhizosphere.

  1999cited by this paper
• Beneficial Effect of Adjunctive Azithromycin in Treatment of Mucoid Pseudomonas aeruginosa Pneumonia in the Murine Model

  1999cited by this paper
• The Pseudomonas aeruginosaQuorum-Sensing Signal MoleculeN-(3-Oxododecanoyl)-l-Homoserine Lactone Has Immunomodulatory Activity

  1998cited by this paper
• Deletion of algK in Mucoid Pseudomonas aeruginosa Blocks Alginate Polymer Formation and Results in Uronic Acid Secretion

  1998influential reference
• Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin.

  1998cited by this paper
• Long-term azithromycin may improve lung function in children with cystic fibrosis.

  1998cited by this paper
• Comparison of Pharmacodynamics of Azithromycin and Erythromycin In Vitro and In Vivo

  1998cited by this paper
• Cellular function of elastase in Pseudomonas aeruginosa: role in the cleavage of nucleoside diphosphate kinase and in alginate synthesis

  1998cited by this paper
• Anti-inflammatory activity of macrolides: a new therapeutic potential?

  1998cited by this paper
• Influence of macrolides on mucoid alginate biosynthetic enzyme from Pseudomonas aeruginosa.

  1997cited by this paper
• The influence of azithromycin on the biofilm formation of Pseudomonas aeruginosa in vitro.

  1996cited by this paper
• Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin

  1996influential reference
• Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects

  1996cited by this paper
• Characterization of elastase-deficient clinical isolates of Pseudomonas aeruginosa

  1996cited by this paper
• Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections

  1995cited by this paper
• Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia in rats.

  1995cited by this paper
• Comparative in vitro exoenzyme-suppressing activities of azithromycin and other macrolide antibiotics against Pseudomonas aeruginosa

  1994cited by this paper
• Profiles of outer membrane proteins and lipopolysaccharide of Pseudomonas aeruginosa grown in the presence of sub-MICs of macrolide antibiotics and their relation to enhanced serum sensitivity.

  1994cited by this paper
• Pathogenesis of cystic fibrosis.

  1993cited by this paper
• Pathogenesis of cystic fibrosis

  1993cited by this paper
• Chronic Pseudomonas aeruginosa lung infection in normal and athymic rats

  1993cited by this paper
• Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response

  1990cited by this paper
• Azithromycin concentrations at the sites of pulmonary infection.

  1990cited by this paper
• Identification and characterization of genes for a second anthranilate synthase in Pseudomonas aeruginosa: interchangeability of the two anthranilate synthases and evolutionary implications

  1990cited by this paper
• Purification, characterization, and immunological cross-reactivity of alginates produced by mucoid Pseudomonas aeruginosa from patients with cystic fibrosis

  1989cited by this paper
• Interactions of Pseudomonas aeruginosa proteases with the cells of the immune system.

  1989cited by this paper
• Scavenging by alginate of free radicals released by macrophages.

  1989cited by this paper
• Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration.

  1989influential reference
• Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms

  1987cited by this paper
• Hypochlorite scavenging by Pseudomonas aeruginosa alginate

  1987cited by this paper
• Isolation and characterization of Pseudomonas aeruginosa PAO mutant that produces altered elastase

  1980cited by this paper
• A new modification of the carbazole analysis: application to heteropolysaccharides.

  1968cited by this paper

• Rugose Small Colony Variants (RSCVs) in Pseudomonas aeruginosa: Pathogenesis, Clinical Implications, and Therapeutic Advancements

  2025cites this paper
• Pharmacological strategies for targeting biofilms in otorhinolaryngologic infections and overcoming antimicrobial resistance (Review)

  2025cites this paper
• Antibiotic-Resistant Pseudomonas aeruginosa: Current Challenges and Emerging Alternative Therapies

  2025cites this paper
• The effect of cCMP and cUMP on growth of Pseudomonas aeruginosa

  2025cites this paper
• Resistance mechanisms and therapeutic strategies for Pseudomonas aeruginosa infections

  2025cites this paper
• Progress in Pathogenesis and Treatment of Protracted Bacterial Bronchitis in Children

  2025cites this paper
• The value of macrolides in the adjuvant treatment of pulmonary fibrosis: maybe a panacea

  2025cites this paper
• The presence of acylated homoserine lactones and diffusible signal factor in bronchoalveolar lavage fluid from horses with clinical exacerbation of severe equine asthma.

  2025cites this paper
• In Vitro and In Vivo Antibacterial and Antibiofilm Activity of Zinc Sulfate (ZnSO4) and Carvacrol (CV) Alone and in Combination with Antibiotics Against Pseudomonas aeruginosa

  2025cites this paper
• A biocompatible β-cyclodextrin inclusion complex containing natural extracts: a promising antibiofilm agent

  2025cites this paper
• A treatment algorithm for hyaluronic acid filler related complications of the face.

  2024cites this paper
• The microenvironment in antibiotic susceptibility testing

  2024cites this paper
• An insight on the powerful of bacterial quorum sensing inhibition

  2024cites this paper
• Biofilm Production and Its Implications in Pediatrics

  2024cites this paper
• Combatting biofilm-mediated infections in clinical settings by targeting quorum sensing

  2024cites this paper
• Sterically hindered phenolic derivatives: effect on the production of Pseudomonas aeruginosa virulence factors, high-throughput virtual screening and ADME properties prediction

  2024cites this paper
• Macrolide resistance through uL4 and uL22 ribosomal mutations in Pseudomonas aeruginosa

  2024cites this paper
• Practical Guidance for Clinical Microbiology Laboratories: Updated guidance for processing respiratory tract samples from people with cystic fibrosis

  2024cites this paper
• Selected strategies to fight pathogenic bacteria

  2023cites this paper
• Biofilms as Battlefield Armor for Bacteria against Antibiotics: Challenges and Combating Strategies

  2023cites this paper
• Predictive factors for identifying macrolide responder in treating chronic rhinosinusitis

  2023cites this paper
• Spiramycin Disarms Pseudomonas aeruginosa without Inhibiting Growth

  2023cites this paper
• Structure–Activity Relationships of Low Molecular Weight Alginate Oligosaccharide Therapy against Pseudomonas aeruginosa

  2023cites this paper
• A gene network-driven approach to infer novel pathogenicity-associated genes: application to Pseudomonas aeruginosa PAO1

  2023cites this paper
• Pathogenesis-based application of biologics for chronic rhinosinusitis: Current and future perspectives.

  2023cites this paper
• The effects of molecular and nanoscopic additives on phospholipid membranes

  2023cites this paper
• Albumin-coated pH-responsive dimeric prodrug-based nano-assemblies with high biofilm eradication capacity.

  2022cites this paper
• Immune Response to Biofilm Growing Pulmonary Pseudomonas aeruginosa Infection

  2022cites this paper
• Pseudomonas aeruginosa Quorum Sensing.

  2022cites this paper
• A Brominated Furanone Inhibits Pseudomonas aeruginosa Quorum Sensing and Type III Secretion, Attenuating Its Virulence in a Murine Cutaneous Abscess Model

  2022cites this paper
• Spatial covariance analysis reveals the residue-by-residue thermodynamic contribution of variation to the CFTR fold

  2022cites this paper
• Azithromycin: An Underappreciated Quinolone-Sparing Oral Treatment for Pseudomonas aeruginosa Infections

  2022cites this paper
• Antimicrobial Treatment of Pseudomonas aeruginosa Severe Sepsis

  2022cites this paper
• Macrolide therapy in Pseudomonas aeruginosa infections causes uL4 ribosomal protein mutations leading to high-level resistance

  2022cites this paper
• An Overview of Biological and Computational Methods for Designing Mechanism-Informed Anti-biofilm Agents

  2021cites this paper
• Filler-induced complications of the lips: 10 years experience with intralesional laser treatment and refinements.

  2021cites this paper
• Novel treatment dynamics for biofilm-related infections

  2021cites this paper
• A review on importance of bioactive compounds of medicinal plants in treating idiopathic pulmonary fibrosis (special emphasis on isoquinoline alkaloids)

  2021cites this paper
• Azithromycin-loaded linolenic acid-modified methoxy poly(ethylene glycol) micelles for bacterial infection treatment

  2021cites this paper
• Challenges of antibiotic resistance biofilms and potential combating strategies: a review

  2021cites this paper
• Quorum sensing inhibitors: Current progress of the natural antimicrobials

  2021cites this paper
• Spatial Covariant Management of Thermodynamics Contributes to Protein Fold Function Through Quality Assurance

  2021cites this paper
• Effect of azithromycin and phenylalanine-arginine beta-naphthylamide on quorum sensing and virulence factors in clinical isolates of Pseudomonas aeruginosa

  2021cites this paper
• Animal models for cystic fibrosis: a systematic search and mapping review of the literature. Part 2: nongenetic models

  2021cites this paper
• Animal models of chronic and recurrent Pseudomonas aeruginosa lung infection: significance of macrolide treatment

  2021cites this paper
• Anti-quorum sensing activity of quercetin in combination with imipenem and cipro oxacin against Pseudomonas aeruginosa PAO1

  2021cites this paper
• Sub-Inhibitory Antibiotic Exposure and Virulence in Pseudomonas aeruginosa

  2021influential citation
• Approaches to Targeting Bacterial Biofilms in Cystic Fibrosis Airways

  2021cites this paper
• Synthesis, characterization and assessment of anti-quorum sensing activity of copper(II)-ciprofloxacin complex against Pseudomonas aeruginosa PAO1

  2020cites this paper
• Inhibitory activity of metal-curcumin complexes on quorum sensing related virulence factors of Pseudomonas aeruginosa PAO1

  2020cites this paper
• Quantitative mapping of mRNA 3’ ends in Pseudomonas aeruginosa reveals a pervasive role for premature 3’ end formation in response to azithromycin

  2020cites this paper
• (-)-α-Pinene reduces quorum sensing and Campylobacter jejuni colonization in broiler chickens

  2020cites this paper
• Inhibitory effect of a novel chicken-derived anti-biofilm peptide on P. aeruginosa biofilms and virulence factors.

  2020cites this paper
• Structure-activity relationships of furanones, dihydropyrrolones and thiophenones as potential quorum sensing inhibitors.

  2020cites this paper
• Effects of a novel anti-biofilm peptide CRAMP combined with antibiotics on the formation of Pseudomonas aeruginosa biofilms.

  2020cites this paper
• Azithromycin concentration in severely inflamed canine external ear canals - a case series.

  2020cites this paper
• Azithromycin potentiates avian IgY effect against Pseudomonas aeruginosa in a murine pulmonary infection model.

  2020cites this paper
• Host responses to mucosal biofilms in the lung and gut

  2020cites this paper
• Burn- and Trauma-Associated Pulmonary Infection

  2020cites this paper
• Was ist gesichert in der Therapie der Mukoviszidose?

  2020cites this paper
• The biofilm‐associated bacterial infections unrelated to indwelling devices

  2020cites this paper
• Low-dose macrolides for treating pediatric rhinosinusitis: A retrospective study and literature review

  2020cites this paper
• Quorum Sensing Interfering Strategies and Their Implications in the Management of Biofilm-Associated Bacterial Infections

  2020cites this paper
• Investigation of the effects of polymymyxins on sub-proteome and lipidome of K. pneumonia

  2019cites this paper
• Update and critical appraisal of topical azithromycin ophthalmic 1%(Azasite) solution in the treatment of ocular infections

  2019cites this paper
• Optimising Medical Management in CRS

  2019cites this paper
• The Quest for Novel Antimicrobial Compounds: Emerging Trends in Research, Development, and Technologies

  2019cites this paper
• Fitting Pieces into the Puzzle of Pseudomonas aeruginosa Type III Secretion System Gene Expression

  2019cites this paper
• Complications of dermal fillers injection in facial augmentation: international and Russian experience

  2019cites this paper
• A permeability-increasing drug synergizes with bacterial efflux pump inhibitors and restores susceptibility to antibiotics in multi-drug resistant Pseudomonas aeruginosa strains

  2019cites this paper
• Nebulized Azithromycin Versus Oral Azithromycin as Anti-Inflammatory Therapy in Children with Cystic Fibrosis: A Prospective Randomized Open-Label Trial

  2019cites this paper
• Inhibition of Quorum Sensing in Pseudomonas aeruginosa: A Review

  2019cites this paper
• Quorum Sensing Inhibition: Current Advances of the Natural Antimicrobial Agents

  2019cites this paper
• Update and critical appraisal of topical azithromycin ophthalmic 1% (Azasite) solution in the treatment of ocular infection

  2019cites this paper
• Utilizing nanoparticles for improving anti-biofilm effects of azithromycin: A head-to-head comparison of modified hyaluronic acid nanogels and coated poly (lactic-co-glycolic acid) nanoparticles.

  2019cites this paper
• Sensitizing Agents to Restore Antibiotic Resistance

  2019cites this paper
• Reconciling Antimicrobial Susceptibility Testing and Clinical Response in Antimicrobial Treatment of Chronic Cystic Fibrosis Lung Infections.

  2019cites this paper
• Antibiotics versus biofilm: an emerging battleground in microbial communities

  2019cites this paper
• Efficacy of Azithromycin in a Mouse Pneumonia Model against Hospital-Acquired Methicillin-Resistant Staphylococcus aureus

  2019cites this paper
• Bacterial Persistence in Biofilms and Antibiotics

  2019cites this paper
• A metabolomics-based analysis of acyl-homoserine lactone quorum sensing in Pseudomonas aeruginosa

  2018cites this paper
• Interference in Bacterial Quorum Sensing: A Biopharmaceutical Perspective

  2018cites this paper
• GÉNÉRALE Empêcher les bactéries de communiquer : diviser pour mieux soigner Prevent bacteria from communicating : Divide and cure

  2018cites this paper
• Control of Biofilm Formation in Healthcare: Recent Advances Exploiting Quorum-Sensing Interference Strategies and Multidrug Efflux Pump Inhibitors

  2018cites this paper
• Targeted Disruption of the Extracellular Polymeric Network of Pseudomonas aeruginosa

  2018cites this paper
• Rational approach in the management of Pseudomonas aeruginosa infections

  2018cites this paper
• Антибактеріальна терапія позалікарняних пневмоній у дітей

  2018cites this paper
• Risk factors for mortality in patients with Pseudomonas aeruginosa pneumonia: Clinical impact of mucA gene mutation.

  2018cites this paper
• Title High -lactamase levels change the pharmacodynamics of -lactam antibiotics in pseudomonas aeruginosa biofilms

  2018cites this paper
• [Prevent bacteria from communicating: Divide to cure].

  2018cites this paper
• HDAC Inhibitors Rescue Multiple Disease-Causing CFTR Variants

  2018cites this paper
• Targeted disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate oligosaccharides

  2018cites this paper
• Combating Pseudomonas aeruginosa lung infections using synthetic host defense peptides

  2017cites this paper
• Impact of azithromycin on the clinical and antimicrobial effectiveness of tobramycin in the treatment of cystic fibrosis.

  2017cites this paper
• Azithromycin attenuates acute radiation-induced lung injury in mice

  2017cites this paper
• Cohesive Properties of the Caulobacter crescentus Holdfast Adhesin Are Regulated by a Novel c-di-GMP Effector Protein

  2017cites this paper
• Exploiting Quorum Sensing Inhibition for the Control of Pseudomonas Aeruginosa and Acinetobacter Baumannii Biofilms.

  2017cites this paper
• Bacterial Biofilm and Antibiotic Resistance

  2017cites this paper
• Synthetic host defense peptide IDR-1002 reduces inflammation in Pseudomonas aeruginosa lung infection

  2017cites this paper
• (S,E)-2-hydroxy-N-(2-hydroxy-5-nitrobenzylidene) propane hydrazide as a quorum sensing inhibitor of Pseudomonas aeruginosa

  2017cites this paper